GB8918893D0 - Pharmacologically active cns compounds - Google Patents

Pharmacologically active cns compounds

Info

Publication number
GB8918893D0
GB8918893D0 GB8918893A GB8918893A GB8918893D0 GB 8918893 D0 GB8918893 D0 GB 8918893D0 GB 8918893 A GB8918893 A GB 8918893A GB 8918893 A GB8918893 A GB 8918893A GB 8918893 D0 GB8918893 D0 GB 8918893D0
Authority
GB
United Kingdom
Prior art keywords
pharmacologically active
active cns
cns compounds
compounds
pharmacologically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB8918893A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to GB8918893A priority Critical patent/GB8918893D0/en
Publication of GB8918893D0 publication Critical patent/GB8918893D0/en
Priority to FI895821A priority patent/FI895821A0/en
Priority to PL28263989A priority patent/PL162957B1/en
Priority to CA002004747A priority patent/CA2004747C/en
Priority to EP95120379A priority patent/EP0727214A3/en
Priority to EP95120378A priority patent/EP0727213B9/en
Priority to MC892083A priority patent/MC2076A1/en
Priority to PT92502A priority patent/PT92502B/en
Priority to CA002271566A priority patent/CA2271566C/en
Priority to CN89109759A priority patent/CN1052306A/en
Priority to AT89312723T priority patent/ATE144422T1/en
Priority to NZ231650A priority patent/NZ231650A/en
Priority to AT95120491T priority patent/ATE235906T1/en
Priority to DD89335316A priority patent/DD292250A5/en
Priority to ES95120378T priority patent/ES2250967T3/en
Priority to MYPI95000966A priority patent/MY115951A/en
Priority to NZ260820A priority patent/NZ260820A/en
Priority to EP03005787A priority patent/EP1325916B1/en
Priority to KR1019890018094A priority patent/KR0145308B1/en
Priority to RU98104443/04A priority patent/RU2171256C2/en
Priority to EP95120380A priority patent/EP0713703A3/en
Priority to SU894742852A priority patent/RU2079493C1/en
Priority to ES03005787T priority patent/ES2300513T3/en
Priority to NZ244881A priority patent/NZ244881A/en
Priority to SK6898-89A priority patent/SK279988B6/en
Priority to NO894887A priority patent/NO178926C/en
Priority to RU95116245A priority patent/RU2121998C1/en
Priority to IL9255889A priority patent/IL92558A/en
Priority to DE68927368T priority patent/DE68927368T2/en
Priority to IE389489A priority patent/IE80711B1/en
Priority to DE68929460T priority patent/DE68929460T2/en
Priority to NZ244880A priority patent/NZ244880A/en
Priority to IL11433589A priority patent/IL114335A/en
Priority to OA59692A priority patent/OA09148A/en
Priority to ES95120491T priority patent/ES2194884T3/en
Priority to IL111627A priority patent/IL111627A/en
Priority to AT03005787T priority patent/ATE384703T1/en
Priority to EP95120491A priority patent/EP0715851B1/en
Priority to APAP/P/1989/000155A priority patent/AP164A/en
Priority to DE68929554T priority patent/DE68929554T2/en
Priority to EP95120377A priority patent/EP0727212A3/en
Priority to EP89312723A priority patent/EP0372934B1/en
Priority to DK198906132A priority patent/DK175796B1/en
Priority to EP05023080A priority patent/EP1681058A3/en
Priority to JP1317401A priority patent/JP2795498B2/en
Priority to AU45964/89A priority patent/AU639216C/en
Priority to HU896444A priority patent/HUT55764A/en
Priority to ES89312723T priority patent/ES2095842T3/en
Priority to AT95120378T priority patent/ATE307585T1/en
Priority to DE68929540T priority patent/DE68929540T2/en
Priority to SG1996008059A priority patent/SG43314A1/en
Priority to UA4742852A priority patent/UA41245C2/en
Priority to MX9203422A priority patent/MX9203422A/en
Priority to LVP-92-337A priority patent/LV10442B/en
Priority to LTIP269A priority patent/LT3415B/en
Priority to GEAP19931548A priority patent/GEP19970891B/en
Priority to AU49154/93A priority patent/AU669929B2/en
Priority to NO941211A priority patent/NO941211D0/en
Priority to PH50547A priority patent/PH31658A/en
Priority to PH50546A priority patent/PH31665A/en
Priority to IL11381895A priority patent/IL113818A0/en
Priority to US08/466,138 priority patent/US5635507A/en
Priority to US08/466,146 priority patent/US5597827A/en
Priority to US08/470,951 priority patent/US5597828A/en
Priority to US08/469,518 priority patent/US5587380A/en
Priority to US08/466,147 priority patent/US5684005A/en
Priority to US08/466,148 priority patent/US5712276A/en
Priority to IL11401995A priority patent/IL114019A0/en
Priority to US08/470,948 priority patent/US5591746A/en
Priority to IL11404095A priority patent/IL114040A0/en
Priority to CN95105850A priority patent/CN1066719C/en
Priority to CN95105625A priority patent/CN1119099A/en
Priority to CN95106817A priority patent/CN1117046A/en
Priority to CN95106811A priority patent/CN1066720C/en
Priority to IL11433595A priority patent/IL114335A0/en
Priority to HU95P/P00754P priority patent/HU211974A9/en
Priority to HU95P/P00740P priority patent/HU211677A9/en
Priority to NO954489A priority patent/NO954489D0/en
Priority to NO953847A priority patent/NO304649B1/en
Priority to FI955940A priority patent/FI955940A0/en
Priority to FI955941A priority patent/FI955941A0/en
Priority to FI955939A priority patent/FI955939A0/en
Priority to AU51952/96A priority patent/AU5195296A/en
Priority to AU51955/96A priority patent/AU690443B2/en
Priority to AU51953/96A priority patent/AU5195396A/en
Priority to AU51956/96A priority patent/AU5195696A/en
Priority to GR960403456T priority patent/GR3022031T3/en
Priority to SK321-98A priority patent/SK32198A3/en
Priority to HK98103302A priority patent/HK1004092A1/en
Priority to DK199900903A priority patent/DK175781B1/en
Priority to CY9900034A priority patent/CY2139B1/en
Priority to UA99116068A priority patent/UA42885C2/en
Pending legal-status Critical Current

Links

GB8918893A 1988-12-07 1989-08-18 Pharmacologically active cns compounds Pending GB8918893D0 (en)

Priority Applications (92)

Application Number Priority Date Filing Date Title
GB8918893A GB8918893D0 (en) 1989-08-18 1989-08-18 Pharmacologically active cns compounds
FI895821A FI895821A0 (en) 1988-12-07 1989-12-05 PHARMACEUTICAL ACTIVE CNS FOERENINGAR.
PL28263989A PL162957B1 (en) 1988-12-07 1989-12-06 Preparation method for the new pyriminide derivatives
CA002004747A CA2004747C (en) 1988-12-07 1989-12-06 Substituted phenylpyrimidines useful in the treatment of cns disorders
EP95120379A EP0727214A3 (en) 1988-12-07 1989-12-06 Substituted phenylpyrimidine derivatives, useful in the treatment or prevention of CNS disorders
EP95120378A EP0727213B9 (en) 1988-12-07 1989-12-06 Substituted phenylpyrimidine derivatives, useful in the treatment or prevention of CNS disorders
MC892083A MC2076A1 (en) 1988-12-07 1989-12-06 COMPOUNDS HAVING AN EFFECT ON THE CENTRAL NERVOUS SYSTEM AND FOR USE AS ACTIVE MEDICINAL SUBSTANCES
PT92502A PT92502B (en) 1988-12-07 1989-12-06 METHOD FOR THE PREPARATION OF PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CA002271566A CA2271566C (en) 1988-12-07 1989-12-06 Substituted phenyl pyrimidines useful in the treatment of cns disorders
CN89109759A CN1052306A (en) 1988-12-07 1989-12-06 The compound that central nervous system is had pharmacologically active
AT89312723T ATE144422T1 (en) 1988-12-07 1989-12-06 CNS-ACTIVE SUBSTANCES
NZ231650A NZ231650A (en) 1988-12-07 1989-12-06 2,4-diamino-5-phenyl-pyrimidine derivatives; medicaments
AT95120491T ATE235906T1 (en) 1988-12-07 1989-12-06 SUBSTITUTED PHENYLPYRIMIDINE DERIVATIVES, FOR THE TREATMENT OR PREVENTION OF CNS DISEASES
DD89335316A DD292250A5 (en) 1988-12-07 1989-12-06 PHARMACOLOGICALLY ACTIVE COMPOUNDS ACTING ON THE CENTRAL NERVOUS SYSTEM
ES95120378T ES2250967T3 (en) 1988-12-07 1989-12-06 SUBSTITUTED PHENYL PYRIMIDINE DERIVATIVES, USEFUL IN THE TREATMENT OR PREVENTION OF CNS DISORDERS.
MYPI95000966A MY115951A (en) 1988-12-07 1989-12-06 Pharmacologically active cns compounds
NZ260820A NZ260820A (en) 1988-12-07 1989-12-06 2,4-diamino-5-(2,3,5-trichlorophenyl)-pyrimidine; medicaments
EP03005787A EP1325916B1 (en) 1988-12-07 1989-12-06 Piperazinyl-substituted phenyl pyrimidine derivatives useful in the treatment or prevention of disorders of the central nervous system
KR1019890018094A KR0145308B1 (en) 1988-12-07 1989-12-06 Pyrimidines compound and pharmacologically active cns compounds
RU98104443/04A RU2171256C2 (en) 1989-08-18 1989-12-06 4-amino-2-(4-methylpiperazine-1-yl)-5-(2,3,5-trichlorophenyl)- -pyrimidine and its salts of acid addition, methods of their synthesis (variants) and pharmaceutical composition
EP95120380A EP0713703A3 (en) 1988-12-07 1989-12-06 Substituted phenylpyrimidine derivatives, useful in the treatment or prevention of CNS disorders
SU894742852A RU2079493C1 (en) 1988-12-07 1989-12-06 Method of synthesis of 4-amino-2-(4-methylpiperazine-1-yl)-5-(2,3,5-trichlorophenyl)- -pyrimidine or its acid additive salt
ES03005787T ES2300513T3 (en) 1988-12-07 1989-12-06 DERIVATIVES OF PHENYL PYRIMIMINES REPLACED BY A PIPERAZINYL GROUP, USEFUL IN THE TREATMENT OR IN THE PREVENTION OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM.
NZ244881A NZ244881A (en) 1988-12-07 1989-12-06 4-amino-2-(4-methylpiperazin-1-yl)-5-(2,3,5-trichlorophenyl)pyrimidine and salts thereof; medicaments
SK6898-89A SK279988B6 (en) 1988-12-07 1989-12-06 Pyrimidines, method of their preparation, pharmaceutical composition them containing, and their use
NO894887A NO178926C (en) 1988-12-07 1989-12-06 Analogous process for the preparation of pharmacologically active pyrimidine compounds
RU95116245A RU2121998C1 (en) 1988-12-07 1989-12-06 Pyrimidine derivatives, method of their synthesis, pharmaceutical composition
IL9255889A IL92558A (en) 1988-12-07 1989-12-06 4-amino-2-(4-methylpiperazin-1-yl)-5-(2,3,5-trichlorophenyl) pyrimidine and pharmaceutical compositions containing it
DE68927368T DE68927368T2 (en) 1988-12-07 1989-12-06 CNS-active substances
IE389489A IE80711B1 (en) 1988-12-07 1989-12-06 Pharmaceutically active CNS compounds
DE68929460T DE68929460T2 (en) 1988-12-07 1989-12-06 Substituted phenylpyrimidine derivatives, for the treatment or prevention of CNS diseases
NZ244880A NZ244880A (en) 1988-12-07 1989-12-06 2-(n-morpholino or n-alkylpiperazino)-4-amino-5-phenyl-pyrimidine derivatives; medicaments
IL11433589A IL114335A (en) 1988-12-07 1989-12-06 Pharmacologically active CNS compounds process for their preparation and pharmaceutical compositions containing them
OA59692A OA09148A (en) 1988-12-07 1989-12-06 Pharmacologically active CNS compounds.
ES95120491T ES2194884T3 (en) 1988-12-07 1989-12-06 DERIVED FROM SUBSTITUTED PHENYL PYRIMIMINE, USEFUL IN THE TREATMENT OR PREVENTION OF DISEASES OF THE CENTRAL NERVOUS SYSTEM.
IL111627A IL111627A (en) 1988-12-07 1989-12-06 Substituted phenylpyrimidine compounds, their preparation and pharmaceutical compositions containing them
AT03005787T ATE384703T1 (en) 1988-12-07 1989-12-06 PIPERAZINYL-SUBSTITUTED PHENYLPYRIMIDENE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF CNS DISEASES
EP95120491A EP0715851B1 (en) 1988-12-07 1989-12-06 Substituted phenylpyrimidine derivatives, useful in the treatment or prevention of CNS disorders
APAP/P/1989/000155A AP164A (en) 1988-12-07 1989-12-06 Pharmacologically active cns compounds
DE68929554T DE68929554T2 (en) 1988-12-07 1989-12-06 Piperazinyl-substituted phenylpyrimidine derivatives for the treatment or prevention of CNS disorders
EP95120377A EP0727212A3 (en) 1988-12-07 1989-12-06 Substituted phenylpyrimidine derivatives, useful in the treatment of prevention of CNS disorders
EP89312723A EP0372934B1 (en) 1988-12-07 1989-12-06 Pharmacologically active CNS compounds
DK198906132A DK175796B1 (en) 1988-12-07 1989-12-06 Substituted phenylpyrimidine derivatives useful in treating or preventing CNS disorders
EP05023080A EP1681058A3 (en) 1988-12-07 1989-12-06 Substituted phenylpyrimidine derivatives useful in the treatment or prevention of CNS disorders
JP1317401A JP2795498B2 (en) 1988-12-07 1989-12-06 Pharmacologically active central nervous system compounds
AU45964/89A AU639216C (en) 1988-12-07 1989-12-06 Pharmaceutically active CNS compounds
HU896444A HUT55764A (en) 1988-12-07 1989-12-06 Process for producing pyrimidine derivatives and pharmaceutical compositions containing them
ES89312723T ES2095842T3 (en) 1988-12-07 1989-12-06 PHARMACOLOGICALLY ACTIVE COMPOUNDS ON THE CNS
AT95120378T ATE307585T1 (en) 1988-12-07 1989-12-06 SUBSTITUTED PHENYLPYRIMIDINE DERIVATIVES, FOR THE TREATMENT OR PREVENTION OF CNS DISEASES
DE68929540T DE68929540T2 (en) 1988-12-07 1989-12-06 Substituted phenylpyrimidines derivatives, for the treatment or prevention of CNS disorders
SG1996008059A SG43314A1 (en) 1988-12-07 1989-12-06 Pharmacologically active cns compounds
UA4742852A UA41245C2 (en) 1988-12-07 1989-12-06 PYRIMIDINE DERIVATIVES, METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITION BASED ON THEM
MX9203422A MX9203422A (en) 1988-12-07 1992-06-25 PHARMACOLOGICALLY ACTIVE COMPOUNDS FOR THE CENTRAL NERVOUS SYSTEM.
LVP-92-337A LV10442B (en) 1988-12-07 1992-12-18 Pharmacologically active cns compounds
LTIP269A LT3415B (en) 1988-12-07 1992-12-30 Method of preparing pyrimidine derivatives
GEAP19931548A GEP19970891B (en) 1988-12-07 1993-09-09 Method for Production of 4-amino- 2(4-methylpiperazine-1-il)-5-(2,3,5-trichlorphenyl) -pyrimidine or the Acid- Additive salts thereof
AU49154/93A AU669929B2 (en) 1988-12-07 1993-10-20 Pharmacologically active CNS compounds
NO941211A NO941211D0 (en) 1988-12-07 1994-04-05 Pharmacologically active pyrimidine compounds and process for their preparation
PH50547A PH31658A (en) 1988-12-07 1995-05-17 Pharmaceutically active cns compounds.
PH50546A PH31665A (en) 1988-12-07 1995-05-17 Pharmaceutical active cns compounds.
IL11381895A IL113818A0 (en) 1988-12-07 1995-05-23 Pharmaceutical active cns compounds and pharmaceutical compositions containing them
US08/466,138 US5635507A (en) 1988-12-07 1995-06-06 Pharmacologically active CNS compounds
US08/466,146 US5597827A (en) 1988-12-07 1995-06-06 Treatment of injury of the spinal cord or brain using 4-amino-2-(4-methylpiperazin-1-yl)-5-(2,3,5-trichlorophenyl)pyrimidine
US08/470,951 US5597828A (en) 1988-12-07 1995-06-06 Certain 2,4-diamino-5-(2,3-dihalophenyl)-6-substituted pyrimidines which are pharmacologically active CNS compounds
US08/469,518 US5587380A (en) 1988-12-07 1995-06-06 Certain 2,4-diamino-5-(2,3,5-TRI-chlorophenyl)-6-substituted-pyrimidines which are pharmacologically active CNS compounds
US08/466,147 US5684005A (en) 1988-12-07 1995-06-06 Pharmacologically active CNS compounds
US08/466,148 US5712276A (en) 1988-12-07 1995-06-06 2-(n-alkylpiperazino or morpholino)-4-amino-5-aryl-pyrimidines
IL11401995A IL114019A0 (en) 1988-12-07 1995-06-06 Pharmacologically active CNS compounds
US08/470,948 US5591746A (en) 1988-12-07 1995-06-06 Treatment of damage from a stroke using 4-amino(4-methylpiperazin-1-yl)-5-(2,3,5-trichlorophenyl)pyrimidine
IL11404095A IL114040A0 (en) 1988-12-07 1995-06-07 Pharmacologically active CNS compounds
CN95105850A CN1066719C (en) 1988-12-07 1995-06-10 Process for preparing compounds having pharmacological activity on the central nervous system
CN95105625A CN1119099A (en) 1988-12-07 1995-06-10 Method for preparing pharmacologically active CNS composition
CN95106817A CN1117046A (en) 1988-12-07 1995-06-10 Method for preparing pharmaceutically active CNS compounds
CN95106811A CN1066720C (en) 1988-12-07 1995-06-10 Process for preparing compounds having pharmacological activity on the central nervous system
IL11433595A IL114335A0 (en) 1988-12-07 1995-06-26 Pharmacologically active CNS compounds
HU95P/P00754P HU211974A9 (en) 1988-12-07 1995-07-03 Pharmaceutically active cns compounds
HU95P/P00740P HU211677A9 (en) 1988-12-07 1995-07-03 Pharmacologically active cns compounds
NO954489A NO954489D0 (en) 1988-12-07 1995-11-08 Analogous process for the preparation of pharmacologically active pyrimidine compounds
NO953847A NO304649B1 (en) 1988-12-07 1995-11-08 Analogous Process for the Preparation of Pharmacologically Active Pyrimidine Compounds
FI955940A FI955940A0 (en) 1988-12-07 1995-12-11 Pharmaceutically active CNS compounds
FI955941A FI955941A0 (en) 1988-12-07 1995-12-11 Pharmaceutically active CNS compounds
FI955939A FI955939A0 (en) 1988-12-07 1995-12-11 Pharmaceutically active CNS compounds
AU51952/96A AU5195296A (en) 1988-12-07 1996-04-24 Pharmacologically active CNS compounds
AU51955/96A AU690443B2 (en) 1988-12-07 1996-04-24 Pharmacologically active CNS compounds
AU51953/96A AU5195396A (en) 1988-12-07 1996-04-24 Pharmacologically active CNS compounds
AU51956/96A AU5195696A (en) 1988-12-07 1996-04-24 Pharmacologically active CNS compounds
GR960403456T GR3022031T3 (en) 1988-12-07 1996-12-13 Pharmacologically active CNS compounds
SK321-98A SK32198A3 (en) 1988-12-07 1998-03-11 4-amino-2-(4-methylpiperazine-1-yl)-5-(2,3,5- -trichlorophenyl)pyrimidine, addition salts thereof with acids, method of its preparation, and pharmaceutical compositions containing it
HK98103302A HK1004092A1 (en) 1988-12-07 1998-04-20 Pharmacologically active cns compounds
DK199900903A DK175781B1 (en) 1988-12-07 1999-06-24 New S-phenyl-pyrimidine derivs. - useful as glutamate release and aspartate release inhibitors for treating CNS disorders
CY9900034A CY2139B1 (en) 1988-12-07 1999-10-12 Pharmacologically active CNS compounds
UA99116068A UA42885C2 (en) 1988-12-07 1999-11-04 4-amino-2-(4-methylpiperazin-1-yl)-5-(2,3,5-trichlorophenyl)pyrimidine showing inhibitory activity of glutamate release, process of its preparation and pharmaceutical composition based thereon

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8918893A GB8918893D0 (en) 1989-08-18 1989-08-18 Pharmacologically active cns compounds

Publications (1)

Publication Number Publication Date
GB8918893D0 true GB8918893D0 (en) 1989-09-27

Family

ID=10661839

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8918893A Pending GB8918893D0 (en) 1988-12-07 1989-08-18 Pharmacologically active cns compounds

Country Status (2)

Country Link
GB (1) GB8918893D0 (en)
RU (1) RU2171256C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR037233A1 (en) 2001-09-07 2004-11-03 Euro Celtique Sa PIRIDINAS ARIL REPLACED, PHARMACEUTICAL COMPOSITIONS AND THE USE OF SUCH COMPOUNDS FOR THE PREPARATION OF A MEDICINAL PRODUCT

Also Published As

Publication number Publication date
RU2171256C2 (en) 2001-07-27

Similar Documents

Publication Publication Date Title
IL114040A0 (en) Pharmacologically active CNS compounds
GB9012311D0 (en) Pharmacologically active cns compounds
GB9012312D0 (en) Pharmacologically active cns compounds
GB8918893D0 (en) Pharmacologically active cns compounds
HRP940540B1 (en) Pharmacologically active cns compounds
ZA9010218B (en) Pharmaceutically active normanyl compounds
ZA899327B (en) Pharmaceutically active cns compounds
GB9218797D0 (en) Pharmacologically active compounds
GB9019593D0 (en) Novel pharmacologically active compounds
GB8908246D0 (en) Pharmaceutically useful compounds
GB8908251D0 (en) Pharmaceutically useful compounds
GB9217426D0 (en) Pharmacologically active compounds
GB9225498D0 (en) Pharmacologically active compounds
GB9216170D0 (en) Pharmacologically active compounds
GB9220543D0 (en) Pharmacologically active compounds
GB9225497D0 (en) Pharmacologically active compounds
GB8910322D0 (en) Therapeutically useful compounds
GB8910601D0 (en) Therapeutically useful compounds
GB8905209D0 (en) Therapeutically useful compounds
GB8925126D0 (en) Therapeutically useful compounds
GB8905210D0 (en) Therapeutically useful compounds
GB8910600D0 (en) Therapeutically useful compounds
GB8925378D0 (en) Therapeutically useful compounds
GB8925379D0 (en) Therapeutically useful compounds
GB8910602D0 (en) Therapeutically useful compounds